BioNexus Gene Lab Corp (BGLC) - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2026-10-22
6:33 pm
Purchase
2025-11-2813GBIONEXUS GENE LAB CORP
BGLC
Fidelion Diagnostics Pte. Ltd.392,329
13.400%
392,329increase
(New Position)
Filing
History
2026-08-14
5:29 pm
Purchase
2026-08-1313DBIONEXUS GENE LAB CORP
BGLC
Tan Lee Su-Leng338,709
11.500%
338,709increase
(New Position)
Filing
History
2024-01-23
07:55 am
Purchase
2024-01-2213GERAYAK PWR SOLUTION GROUP INC.
RAYA
Erayak Power Solution Group Inc.200,000
18.180%
200,000increase
(New Position)
Filing
History
2024-01-16
5:43 pm
Purchase
2023-12-1113DBIONEXUS GENE LAB CORP COM
BGLC
Lai Soo Kow125,000
7.025%
125,000increase
(New Position)
Filing
History
2023-10-17
11:46 am
Purchase
2023-07-1913GBIONEXUS GENE LAB CORP COM
BGLC
Wong Chan Chong125,000
7.030%
125,000increase
(New Position)
Filing
History